Skip to Content

MD Anderson Events

Transport Oncophysics, and iNPG-pDox for the cure of visceral metastases

Transport Oncophysics, and iNPG-pDox for the cure of visceral metastases

Distinguished Lecture Series in Experimental Therapeutics

 

Synopsis: Transport Oncophysics views cancer as a proliferative disease of  mass transport dysregulation at the subcellular, microenvironmental, and systemic levels. The fundamental aspects of the dysregulation are the body’s biological barriers, and their evolution throughout carcinogenesis. We have employed this framework to develop a novel multicomponent drug (iNPG-pDox) that has yielded unprecedented results in the treatment of preclinical models of triple-negative breast cancer with lung and liver metastases, yielding about 40-50% complete cures in different murine models.

 

Date: 9/20/17, 9am to 10:30am
Time: 9/20/17, 9am to 10:30am
Location: 4SCR1.1110
Format: Seminar/Conference
Speaker: Mauro Ferrari, PhD
Speaker Bio: Mauro Ferrari, PhD, is the Executive Vice President of Houston Methodist and the President and CEO of the Houston Methodist Research Institute where he is the Ernest Cockrell Jr. Presidential Distinguished Chair. As the Director of the Houston Methodist Institute for Academic Medicine, Ferrari oversees all research and education programs at Houston Methodist, over 1,200 research employees and credentialed clinicians executing more than 800 clinical protocols. He also serves as the Senior Associate Dean of the Weill Cornell Medical College, the primary academic affiliate of Houston Methodist and holds Adjunct and Honorary Professorships at many universities around the world.
Contact: Roseann Martinez - 32718 - rmartinez@mdanderson.org